CoChat

Update on incretin hormones

Open access
Phillips, Liza K., Prins, Johannes B. · 2011 · Annals of the New York Academy of Sciences
Cited by 119

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

The incretin hormones glucagon‐like‐peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) are released from the intestine following oral ingestion of nutrients. Incretins promote insulin secretion, while GLP‐1 also inhibits glucagon release and gastric emptying, minimizing postprandial glucose excursions. The incretins share similar effects on the pancreatic β cell; however, there are a number of differences in extrapancreatic actions. Type 2 diabetes (T2DM) is associated with abnormal incretin physiology, and although treatment with GIP is ineffective, GLP‐1 effects are preserved. The current incretin‐based approaches to T2DM include the GLP‐1 agonists that are resistant to the serine protease dipeptidylpeptidase‐4 (DPP4), which normally rapidly degrades the incretins, and DPP4 inhibitors (DPP4i). Incretin‐based treatments have provoked much interest due to use‐associated weight loss (GLP‐1 agonists), minimal hypoglycemia, and potential for positive effects on pancreatic β cell biology and the cardiovascular system. However, the long‐term safety of these agents has yet to be established. This review outlines the current understanding of incretin biology, available data pertaining to incretin‐based treatment in T2DM, and differences between GLP‐1 and DPP4i therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2012.06491.x

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Cited by

See all 119

Metadata

Authors
Phillips, L. K., & Prins, J. B.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2011-12
Volume
1243
Issue
1
Pages
E55-74
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W1567873331
Cited by
119
References
68
FWCI
12.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Update on incretin hormones. https://app.cochat.ai/papers/10.1111/j.1749-6632.2012.06491.x
The paper
Phillips, L. K., & Prins, J. B. (2011). Update on incretin hormones. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2012.06491.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.